Comparing two acid reducers for healing esophagus damage
Treatments studied
Part of Digestive system clinical trials.
This trial compares two medicines—vonoprazan and esomeprazole—to see which is better at healing acid damage to the esophagus (erosive esophagitis). If you have had heartburn and an endoscopy confirmed inflammation, you may be eligible for this study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- A doctor has confirmed you have acid reflux disease (GERD) and also has seen signs of tissue damage in your esophagus during an endoscopy test
- You are willing to follow the treatment plan and attend follow-up visits
- You do not have an allergy to acid-reducing medicines like esomeprazole or vonoprazan
- You do not have stomach or duodenal ulcers, H. pylori infection, or a history of surgery or cancer in the esophagus or stomach
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests vonaprazan (two doses) against esomeprazole to see which better heals moderate-to-severe reflux esophagitis (a damaged esophagus from acid reflux) in 8 weeks. You may qualify if you have had heartburn or regurgitation for at least a month and your doctor found grade B, C, or D damage on an endoscopy.
This trial compares two medicines that reduce stomach acid to help heal ulcers that form after a procedure called ESD, which removes abnormal stomach tissue. The goal is to see if one medicine works better and has fewer side effects.
This study compares two medications—vonoprazan and esomeprazole—to see which one heals acid reflux-related damage in the esophagus better after POEM surgery for achalasia. If you have had POEM and now have heartburn and moderate to severe esophagitis, this trial may help find the best treatment for you.
This study compares two treatments that reduce stomach acid after a bleeding ulcer has been repaired with an endoscope. It aims to find which one is better at preventing the ulcer from bleeding again.
This study compares two medications, rabeprazole and vonoprazan, to see which one works better at preventing ulcers that can form after a procedure to treat varices (enlarged veins) in the esophagus. If you have cirrhosis and varices, this trial may help reduce pain and bleeding after your treatment.
This study tests a new medicine called vonoprazan to see if it can reduce episodes of heartburn in people who have GERD but no damage to their esophagus. It compares the medicine to a placebo (a pill with no active ingredient) over 24 weeks.
Hear when a new Erosive Esophagitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.